Hour24 News
Sophisticated and simple
-
Overview of the Quarter Compugen released its third-quarter 2025 results, underscoring advances in its oncology program and the ongoing development of the COM701 program. The…
-
BlueWillow’s Intranasal Bird Flu Vaccine: A New Era for Mucosal Immunity BlueWillow Biologics, a leading clinical-stage biotech company, has announced positive findings from a peer-reviewed…
